All Updates

 Statement from American Cancer Society Cancer Action Network (ACS CAN) Nebraska Government Relations Director Megan Word   LINCOLN, Neb . – “Late last week, the Nebraska Revenue Committee advanced a bill that fails to prioritize reducing Nebraska’s high tobacco burden. The Committee missed an opportunity to improve the health of Nebraskans

In a major victory for public health, a three-judge panel of the U.S. Court of Appeals for the Fifth Circuit has unanimously upheld graphic health warnings on cigarette packs and advertising required under a 2020 FDA rule .

A series of TV advertisements paid for by the American Cancer Society Cancer Action Network (ACS CAN) launched today. The latest ad calls attention to the diverse range of people caught in the Medicaid coverage gap, including military veterans, their families, and cancer patients. The ad is hitting the airwaves as the Senate continues its work toward its plan to provide more hard-working Mississippians access to health care through Medicaid.

The following was originally published in the Albany Times Union on March 21, 2024. Over the past 30 years, the risk of dying from cancer has steadily declined. This trend can partially be explained by declines in smoking rates, progress in early cancer detection and advances in

Nation’s Leading Cancer Advocacy Organization Urges Support of LD2028 Minority Report to Protect Public Health

Today, the American Cancer Society Cancer Action Network submitted a statement for the record to the House Energy & Commerce Committee Health Subcommittee in regards to their hearing on Evaluating Approaches to Diagnostic Test Regulation and the impact of the FDA’s proposed rule.

ATLANTA, Georgia – March 21, 2024 – The Georgia Senate’s regulated industries committee failed to pass HB 1077 today in a tied vote. The bill would have cleared the way for a customized solution to closing the coverage gap in Georgia. PeachCare Plus would help nearly 450,000 Georgians access

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion.